The global plasma-derived medicine market was valued at approximately USD 15.96 billion in 2023 and is anticipated to reach USD 37.4 billion by 2034, reflecting a compound annual growth rate (CAGR) of 8.05% from 2024 to 2034. The rising demand for plasma-derived medicines is driven by their critical applications in addressing various plasma protein dysfunctions and deficiencies.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5302
In September 2024, Viromed Medical AG plans to acquire all shares of ActivCell Group, with negotiations expected to begin immediately. This acquisition could facilitate the integration of plasma medicine into routine practice through ActivCell Group’s CellPen device line, which effectively utilizes cold plasma technology in portable, cordless “pens.”
In December 2023, PlasmaGen Biosciences, a biopharmaceutical company, raised approximately $27 million (around ₹225 crore) in equity funding. This investment will support the Bengaluru-based firm’s expansion of its plasma product line.
In May 2023, the New York Blood Center, Inc. (NYBC) invested $50 million in its inaugural fund, NYBC Ventures, aimed at driving innovation in cellular therapies, enabling technologies, and blood-related sectors.
The plasma-derived medicine market is poised for growth, particularly due to the aging population and advancements in healthcare that enhance diagnosis and treatment. Identifying new therapeutic applications for plasma-derived medicines will be crucial. There is currently no viable alternative to intravenous immunoglobulin (IVIG), and its therapeutic scope may expand to include neurological conditions such as neuropathic pain, chronic fatigue syndrome, and post-polio syndrome. Additionally, researchers are investigating potential applications for albumin in treating conditions like sepsis, cirrhosis, stroke, Alzheimer’s disease, and malaria.
Plasma-derived medicines involve costly manufacturing processes that utilize human plasma, which is a complex raw material. These products tend to be expensive due to stringent safety measures, high-quality raw materials, and advanced technologies required for their production.
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/plasma-derived-medicine-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5302
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The Molecular Cloning Market is expected to continue its growth trajectory with a projected increase from $5.53 billion in 2025… Read More
The global pharma CRO services market is on a solid growth path. It’s expected to jump from USD 36.66 billion… Read More
The use of Artificial Intelligence (AI) in mental health care is growing fast. In 2024, this market was worth about… Read More
The global cancer vaccines market is on a strong growth path. It's expected to expand from $11.38 billion in 2025… Read More
The global bioprocess containers market is on a major growth path. Valued at around $3.12 billion in 2024, it’s expected… Read More
The world is moving towards personalized healthcare, and patient-centric apps are at the forefront of this shift. In 2024, the… Read More